Financials

  • Market Capitalization 208.63 M
  • Employee 81
  • Founded 1999
  • CEO N/A
  • Website www.agenusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000C8SWQ9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.63
ratio cours/chiffre d'affaires
0.86

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3601
RNA
Atrium Therapeutics, Inc. - Common Stock
12.32 USD+0.82%-7.85%-3.37%-82.48%210.74 M USD
3618
IMUX
Immunic, Inc. - Common Stock
15.00 USD+2.11%+1.56%+6.16%+1685.71%204.32 M USD
3628
CLLS
Cellectis S.A. - American Depositary Shares
2.81 USD-2.43%-9.65%-10.79%+42.64%201.62 M USD
3633
NERV
Minerva Neurosciences, Inc - Common Stock
4.33 USD+7.71%-6.28%-1.37%+147.43%201.73 M USD

Nouvelles